18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies
Few studies investigate the natural history of patients on long-term treatment for opioid use disorder (OUD). We evaluated the long-term efficacy, safety, and tolerability experience of monthly extended-release buprenorphine (BUP-XR) in participants seeking treatment for OUD, via integrated analysis of phase 3 studies.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Daniel Rutrick, Susan M. Learned, Brent Boyett, David Hassman, Sunita Shinde, Yue Zhao Source Type: research